Lung Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-10
EMA Authorised: Esbriet (Pirfenidone) — H.A.C. Pharma
Authorised status for Esbriet (pirfenidone) in the EU for idiopathic pulmonary fibrosis and related respiratory conditions.